Dennis Langer, Director at MYRIAD GENETICS INC (MYGN), sold 15,000 shares at $82.72 ($1.2M) on 2009-02-05, disclosed to the SEC on 2009-02-05.
Open-market sale of $1.2M MYGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $82.72 | 5,000 | $414K | 33.3% |
| 2 | $82.72 | 10,000 | $827K | 66.7% |
| Total | $82.72 avg | 15,000 | $1.2M | 100% |
| Filing → |
| MYGN | SELL | 2021-08-05 | $1.0M | — | Filing → |
| DRNA | SELL | 2018-08-17 | $613K | — | Filing → |
| MYGN | SELL | 2018-06-08 | $1.6M | — | Filing → |